Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Patients With Cardiovascular Disease
NCT00282984Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started Feb 2006; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00282984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282984.